[PSTX] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -329.77%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 130,362 31 0 0 0 2,985 9,768 53.98%
PBT -63,458 -125 -130 -86,527 -44,606 -20,189 -5,340 51.03%
Tax 544 -4,529 -2,582 6,112 -202 -527 -765 -
NP -64,002 4,404 2,452 -92,639 -44,404 -19,662 -4,575 55.19%
Tax Rate - - - - - - - -
Total Cost 194,364 -4,373 -2,452 92,639 44,404 22,647 14,343 54.37%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -49.10 14,097.81 0.00 0.00 0.00 -658.69 -46.84 0.78%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.89 0.07 0.07 -2.33 -1.24 -0.49 -0.08 49.38%
EPS Diluted -0.89 0.07 0.07 -2.33 -1.24 -0.49 -0.08 49.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.